CA2581869A1 - Syntheses de conjugues polyaminiques d'arn interferents courts (arnic), et conjugues ainsi obtenus - Google Patents
Syntheses de conjugues polyaminiques d'arn interferents courts (arnic), et conjugues ainsi obtenus Download PDFInfo
- Publication number
- CA2581869A1 CA2581869A1 CA002581869A CA2581869A CA2581869A1 CA 2581869 A1 CA2581869 A1 CA 2581869A1 CA 002581869 A CA002581869 A CA 002581869A CA 2581869 A CA2581869 A CA 2581869A CA 2581869 A1 CA2581869 A1 CA 2581869A1
- Authority
- CA
- Canada
- Prior art keywords
- polyamine
- rna
- group
- conjugate
- sirna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 CCCC*C(C1)C1IN Chemical compound CCCC*C(C1)C1IN 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62490604P | 2004-11-04 | 2004-11-04 | |
US60/624,906 | 2004-11-04 | ||
PCT/US2005/040227 WO2006052854A2 (fr) | 2004-11-04 | 2005-11-04 | Syntheses de conjugues polyaminiques d'arn interferents courts (arnic), et conjugues ainsi obtenus |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2581869A1 true CA2581869A1 (fr) | 2006-05-18 |
Family
ID=36337090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002581869A Abandoned CA2581869A1 (fr) | 2004-11-04 | 2005-11-04 | Syntheses de conjugues polyaminiques d'arn interferents courts (arnic), et conjugues ainsi obtenus |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1817324A2 (fr) |
JP (1) | JP2008519053A (fr) |
AU (1) | AU2005304816A1 (fr) |
CA (1) | CA2581869A1 (fr) |
WO (1) | WO2006052854A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101388320B1 (ko) | 2005-12-15 | 2014-04-22 | 뽈리쁠뤼스-트랑스펙씨옹 | 양이온성 올리고뉴클레오티드, 이를 제조하기 위한 자동화방법 및 이의 용도 |
EP2075342A1 (fr) | 2007-12-27 | 2009-07-01 | PolyPlus Transfection | Procédé d'hybridisation d'acides nucléiques |
FR2926818B1 (fr) * | 2008-01-30 | 2012-04-06 | Centre Nat Rech Scient | siRNA CATIONIQUES, SYNTHESE ET UTILISATION POUR L'ARN INTERFERENCE |
EP3030244B1 (fr) * | 2013-08-07 | 2021-04-21 | Arrowhead Pharmaceuticals, Inc. | Polyconjugués pour l'administration de déclencheurs d'arni à des cellules tumorales in vivo |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6794545B1 (en) * | 1999-04-30 | 2004-09-21 | Slil Biomedical Corporation | Conformationally restricted polyamine analogs as disease therapies |
-
2005
- 2005-11-04 AU AU2005304816A patent/AU2005304816A1/en not_active Abandoned
- 2005-11-04 JP JP2007540118A patent/JP2008519053A/ja active Pending
- 2005-11-04 WO PCT/US2005/040227 patent/WO2006052854A2/fr active Application Filing
- 2005-11-04 EP EP05825874A patent/EP1817324A2/fr not_active Withdrawn
- 2005-11-04 CA CA002581869A patent/CA2581869A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2005304816A1 (en) | 2006-05-18 |
WO2006052854A3 (fr) | 2006-10-12 |
WO2006052854A2 (fr) | 2006-05-18 |
JP2008519053A (ja) | 2008-06-05 |
EP1817324A2 (fr) | 2007-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11767531B2 (en) | Defined multi-conjugates oligonucleotides | |
US6878805B2 (en) | Peptide-conjugated oligomeric compounds | |
US20230110095A1 (en) | Novel compound and application thereof | |
AU2018215684B2 (en) | Multimeric oligonucleotides having decreased kidney clearance | |
JP2018518186A5 (fr) | ||
KR20100106314A (ko) | Rna 간섭 효과가 높은 지질 수식 2중쇄 rna | |
AU728176B2 (en) | Nucleic acid ligand complexes | |
CN115851723B (zh) | 一种抑制lpa基因表达的rna抑制剂及其应用 | |
US20220025368A1 (en) | Bispecific antisense oligonucleotides for dystrophin exon skipping | |
CA3153026A1 (fr) | Modifications chimiques de petits arn interferents avec une teneur minimale en fluor | |
US20040033973A1 (en) | Compounds and oligomeric compounds comprising novel nucleobases | |
CN114466929A (zh) | 具有增强的生物活性的多聚体寡核苷酸的皮下递送 | |
CA2581869A1 (fr) | Syntheses de conjugues polyaminiques d'arn interferents courts (arnic), et conjugues ainsi obtenus | |
US20040019000A1 (en) | Polyalkyleneamine-containing oligomers | |
JP7231147B2 (ja) | Rna導入試薬及びその利用 | |
CA3132505A1 (fr) | Oligonucleotides multimeres a bioactivite amelioree | |
Alagia | Modulation of the RNAi pathway by chemically modified siRNA molecules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |